Using a pooled-genome wide shRNA library screen and global proteomic profiling, we demonstrated that jerantinine A (JA) targets the cancer spliceosome through the upregulation of SF3B1 and SF3B3 proteins in breast cancer cells. This evidence concerns the gene SF3B3 and breast cancer.